{"log_id": 2746173821143015189, "direction": 0, "words_result_num": 27, "words_result": [{"probability": {"variance": 0.000243, "average": 0.99469, "min": 0.911556}, "location": {"width": 829, "top": 227, "height": 30, "left": 216}, "words": "分布:在替诺福韦浓度范围0.01~25μg/mL之间,其在体外与人血浆或血清蛋白的体"}, {"probability": {"variance": 0, "average": 0.984091, "min": 0.984091}, "location": {"width": 22, "top": 240, "height": 22, "left": 1156}, "words": "品"}, {"probability": {"variance": 0.001639, "average": 0.985949, "min": 0.794782}, "location": {"width": 816, "top": 258, "height": 29, "left": 217}, "words": "内结合率分别小于0.7%和7.2%。替诺福韦以1.0mg/kg和3.0mg/kg的剂量静脉注射"}, {"probability": {"variance": 0.002204, "average": 0.980089, "min": 0.734198}, "location": {"width": 586, "top": 288, "height": 29, "left": 217}, "words": "给药后,稳态分布容积分别是1.3±0.6L/kg和1.2±0.4L/kg"}, {"probability": {"variance": 0.000661, "average": 0.99432, "min": 0.843217}, "location": {"width": 788, "top": 341, "height": 29, "left": 218}, "words": "代谢和清除:体外研究表明,替诺福韦二吡呋酯和替诺福韦都不是CYP酶的底物"}, {"probability": {"variance": 1e-06, "average": 0.999311, "min": 0.994338}, "location": {"width": 832, "top": 392, "height": 30, "left": 216}, "words": "替诺福韦静脉注射给药后72小时内,在尿液中以替诺福韦药物原型的形式大约回收了"}, {"probability": {"variance": 4.4e-05, "average": 0.996649, "min": 0.967605}, "location": {"width": 822, "top": 421, "height": 29, "left": 216}, "words": "给药剂量的70%~80%。富马酸替诺福韦二吡呋酯单次口服给药后,替诺福韦的终末"}, {"probability": {"variance": 2.2e-05, "average": 0.997493, "min": 0.973349}, "location": {"width": 801, "top": 451, "height": 30, "left": 216}, "words": "半衰期大约为17小时。富马酸替诺福韦二吡呋酯300mg每天一次多次口服给药后"}, {"probability": {"variance": 7.7e-05, "average": 0.994984, "min": 0.959685}, "location": {"width": 616, "top": 483, "height": 27, "left": 229}, "words": "(进食状态下),24小时内在尿液中可回收给药剂量的32±10%"}, {"probability": {"variance": 0.000716, "average": 0.994513, "min": 0.834938}, "location": {"width": 828, "top": 533, "height": 30, "left": 215}, "words": "替诺福韦通过肾小球过滤和肾小管主动分泌相结合的方式被清除。与其他通过肾脏被"}, {"probability": {"variance": 0.000132, "average": 0.994571, "min": 0.953516}, "location": {"width": 356, "top": 562, "height": 28, "left": 216}, "words": "清除的药物可能产生清除方面的竞争"}, {"probability": {"variance": 0, "average": 0.999811, "min": 0.99949}, "location": {"width": 90, "top": 614, "height": 29, "left": 217}, "words": "特殊人群"}, {"probability": {"variance": 8e-06, "average": 0.998133, "min": 0.988945}, "location": {"width": 536, "top": 667, "height": 28, "left": 216}, "words": "种族:高加索人和中国人之间替诺福韦药代动力学相似"}, {"probability": {"variance": 2e-06, "average": 0.999204, "min": 0.993441}, "location": {"width": 578, "top": 717, "height": 27, "left": 216}, "words": "性别:在男性和女性受试者中,替诺福韦的药代动力学相似"}, {"probability": {"variance": 0.000539, "average": 0.990375, "min": 0.869034}, "location": {"width": 816, "top": 769, "height": 27, "left": 218}, "words": "儿童:52例HBV感染儿童受试者(12至<18岁)口服富马酸替诺福韦二吡呋酯300"}, {"probability": {"variance": 5.7e-05, "average": 0.997085, "min": 0.967787}, "location": {"width": 723, "top": 798, "height": 30, "left": 219}, "words": "mg片每日一次后,替诺福韦的暴露量与HV-1感染成人及儿童暴露量相似"}, {"probability": {"variance": 0.000215, "average": 0.995683, "min": 0.924608}, "location": {"width": 528, "top": 851, "height": 27, "left": 217}, "words": "老年人:老年人(>65岁)中没有进行药代动力学试验"}, {"probability": {"variance": 0.000526, "average": 0.993478, "min": 0.857625}, "location": {"width": 831, "top": 902, "height": 31, "left": 217}, "words": "肝功能损害:在中度到重度肝功能损害的非HIV感染受试者中,富马酸替诺福韦二吡"}, {"probability": {"variance": 5e-06, "average": 0.998642, "min": 0.987696}, "location": {"width": 817, "top": 930, "height": 31, "left": 218}, "words": "呋酯300mg单次给药后,对替诺福韦的药代动力学进行了研究。与没有肝功能损害"}, {"probability": {"variance": 2e-06, "average": 0.999101, "min": 0.994537}, "location": {"width": 830, "top": 961, "height": 28, "left": 216}, "words": "的受试者相比,肝功能损害的患者中替诺福韦的药代动力学没有实质性的改变。在肝"}, {"probability": {"variance": 5.1e-05, "average": 0.997036, "min": 0.962365}, "location": {"width": 643, "top": 990, "height": 28, "left": 217}, "words": "功能损害的患者中不需要改变富马酸替诺福韦二吡呋酯的给药剂量"}, {"probability": {"variance": 1.8e-05, "average": 0.998085, "min": 0.980903}, "location": {"width": 813, "top": 1040, "height": 30, "left": 216}, "words": "肾功能损害:肾功能损害的受试者中替诺福韦的药代动力学发生改变(参见“注意事"}, {"probability": {"variance": 0.006436, "average": 0.978958, "min": 0.499111}, "location": {"width": 812, "top": 1071, "height": 27, "left": 217}, "words": "项-肾功能损害”)。在肌酐清除率低于50mL分钟或晚期肾病(ESRD)要求透析的"}, {"probability": {"variance": 0.022365, "average": 0.941359, "min": 0.432503}, "location": {"width": 819, "top": 1100, "height": 28, "left": 217}, "words": "受试者中,替诺福韦的Cmx和AUC0-增加表16。建议在肌酐清除率50mL分钟的"}, {"probability": {"variance": 0.001801, "average": 0.988805, "min": 0.755239}, "location": {"width": 804, "top": 1129, "height": 27, "left": 216}, "words": "患者中或在患晚期肾病要求透析的患者中更改富马酸替诺福韦立吡呋酯的给药间期"}, {"probability": {"variance": 0.000594, "average": 0.985902, "min": 0.91417}, "location": {"width": 179, "top": 1157, "height": 26, "left": 227}, "words": "(参见“用法用量”)"}, {"probability": {"variance": 0.015282, "average": 0.783373, "min": 0.659754}, "location": {"width": 33, "top": 1492, "height": 28, "left": 1029}, "words": "35"}], "language": 3}